We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-14.64%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$770B
AUM Growth
+$29B
Cap. Flow
+$170B
Cap. Flow %
22.02%
Top 10 Hldgs %
15.63%
Holding
8,351
New
166
Increased
4,644
Reduced
2,362
Closed
325

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$9.31B
2
AAPL icon
Apple
AAPL
+$8.69B
3
AMZN icon
Amazon
AMZN
+$4.42B
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.04B
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.13B

Sector Composition

Rank Sector Weight
1 Technology 17.83%
2 Healthcare 11.56%
3 Financials 9.35%
4 Consumer Discretionary 7.77%
5 Communication Services 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRAD icon
5076
Sportradar
SRAD
$3.95B
$698K ﹤0.01%
88,401
-22,841
-21% -$250K
QAT icon
5077
iShares MSCI Qatar ETF
QAT
$63.8M
$697K ﹤0.01%
33,344
-8,610
-21% -$198K
APTO
5078
DELISTED
Aptose Biosciences, Inc.
APTO
$697K ﹤0.01%
2,086
+179
+9% +$85.6K
HMPT
5079
DELISTED
Home Point Capital, Inc Common Stock
HMPT
$696K ﹤0.01%
177,596
+176,259
+13,183% +$620K
KNTE
5080
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$693K ﹤0.01%
54,938
+16,247
+42% +$151K
SPLP
5081
DELISTED
STEEL PARTNERS HOLDINGS L.P.
SPLP
$692K ﹤0.01%
16,518
+1,961
+13% +$82.7K
FRPH icon
5082
FRP Holdings
FRPH
$415M
$691K ﹤0.01%
22,888
+18,192
+387% +$530K
KNDI
5083
Kandi Technologies Group
KNDI
$63.1M
$691K ﹤0.01%
287,890
-164,861
-36% -$429K
DFH icon
5084
Dream Finders Homes
DFH
$1.25B
$690K ﹤0.01%
64,973
+12,334
+23% +$195K
PPIH
5085
Perma-Pipe International
PPIH
$211M
$690K ﹤0.01%
76,639
+6,108
+9% +$68.1K
INST
5086
DELISTED
Instructure Holdings, Inc.
INST
$690K ﹤0.01%
30,399
+4,168
+16% +$78.6K
GII icon
5087
State Street SPDR S&P Global Infrastructure ETF
GII
$929M
$687K ﹤0.01%
12,870
+8,300
+182% +$469K
PINE
5088
Alpine Income Property Trust
PINE
$343M
$686K ﹤0.01%
38,260
-1,614
-4% -$29.8K
TGA
5089
DELISTED
Transglobe Energy Corp
TGA
$682K ﹤0.01%
201,131
+1,297
+0.6% +$5.55K
URGN icon
5090
UroGen Pharma
URGN
$2.26B
$681K ﹤0.01%
83,276
+43,383
+109% +$298K
CTSO icon
5091
Cytosorbents Corp
CTSO
$22.7M
$677K ﹤0.01%
309,112
+117,763
+62% +$270K
DFAI
5092
Dimensional International Core Equity Market ETF
DFAI
$17.9B
$676K ﹤0.01%
28,018
+16,358
+140% +$429K
SPFF icon
5093
Global X SuperIncome Preferred ETF
SPFF
$141M
$676K ﹤0.01%
65,704
-2,283
-3% -$24.1K
PKOH icon
5094
Park-Ohio Holdings
PKOH
$693M
$675K ﹤0.01%
42,520
+20,566
+94% +$289K
PGC icon
5095
Peapack-Gladstone Financial
PGC
$800M
$674K ﹤0.01%
22,715
+2,297
+11% +$73.5K
VITL icon
5096
Vital Farms
VITL
$483M
$673K ﹤0.01%
76,899
+17,069
+29% +$182K
CVM icon
5097
CEL-SCI Corp
CVM
$26M
$671K ﹤0.01%
4,979
+1,697
+52% +$177K
SCWX
5098
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$667K ﹤0.01%
61,447
+12,756
+26% +$145K
AVPT icon
5099
AvePoint
AVPT
$2.75B
$664K ﹤0.01%
153,086
+41,434
+37% +$210K
DAWN
5100
DELISTED
Day One Biopharmaceuticals
DAWN
$662K ﹤0.01%
37,040
+20,587
+125% +$213K

Similar funds

Morgan Stanley's Q2 2022 Portfolio in Review

As of Q2 2022, Morgan Stanley held 8,351 positions worth $770B, up 3.9% from $741B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Morgan Stanley deployed $170B of net new capital in Q2 2022, opening 166 new positions and adding to 4,644 existing holdings. Its largest new stake was Goldman Sachs Future Planet Equity ETF: 2,930,007 shares worth $84M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $3.31B trimmed.

  • Morgan Stanley's largest Q2 2022 buy was Goldman Sachs Future Planet Equity ETF: 2,930,007 shares worth $84M.
  • Morgan Stanley added most to Microsoft in Q2 2022, an estimated $9.31B increase.
  • Morgan Stanley's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.31B.
  • Morgan Stanley fully exited BP Midstream Partners LP Common Units representing Limited Partner Interests in Q2 2022, selling an estimated $156M.
  • Morgan Stanley's ten largest holdings make up 16% of its $770B portfolio in Q2 2022.
  • Morgan Stanley opened 166 new positions and closed 325 in Q2 2022.
  • Morgan Stanley's portfolio value rose 3.9% quarter-over-quarter to $770B.

Based on Morgan Stanley's 13F filing for Q2 2022, filed 15 Aug 2022.